NEW YORK STATE DEPARTMENT OF HEALTH 08/06 ... - eMedNY

More documents

Recommendations

Info

NEW YORK STATE DEPARTMENT OF HEALTH 02/28/2014 PAGE: 298LIST OF MEDICAID REIMBURSABLE DRUGSRX TYPE: 01 PRICING ERRORS ARE NOT REIMBURSABLE PRICES EFFECTIVE 02/28/2014LTM BASISIND NDC CODE MRA COST COST ALTERNATE FORMULARY DESCRIPTION PA CD LABELER OF MRA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 00037-7025-60 8.33750 24.09628 OPTIVAR 0.05% DROPS G MEDA PHARMACEUT MLBND 00299-3822-30 14.55820 ORACEA 40 MG CAPSULE G GALDERMA LABORA EAGEN 51672-1335-05 9.00100 ORALONE 0.1% PASTE 0 TARO PHARM USA GMBEX 57844-0151-01 1.59202 ORAP 1 MG TABLET 0 GATE PHARM EABEX 57844-0187-01 2.12247 ORAP 2 MG TABLET 0 GATE PHARM EABND 59630-0700-48 6.82743 ORAPRED ODT 10 MG TABLET G CONCORDIA PHARM EABND 59630-0701-48 10.77962 ORAPRED ODT 15 MG TABLET G CONCORDIA PHARM EABND 59630-0702-48 15.36053 ORAPRED ODT 30 MG TABLET G CONCORDIA PHARM EAGEN 59630-0710-08 0.07700 ORAPRED 15 MG/5 ML SOLUTION G CONCORDIA PHARM MLGEN 59630-0710-10 0.07700 ORAPRED 15 MG/5 ML SOLUTION G CONCORDIA PHARM ML--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 00003-2188-11 629.21055 ORENCIA 125 MG/ML SYRINGE G BMS PRIMARYCARE MLBND 00003-2188-31 588.59865 ORENCIA 125 MG/ML SYRINGE G BMS PRIMARYCARE MLBND 66621-1010-06 346.08109 ORFADIN 10 MG CAPSULE 0 RARE DISEASE EABND 66621-1002-06 69.21646 ORFADIN 2 MG CAPSULE 0 RARE DISEASE EABND 66621-1005-06 173.04033 ORFADIN 5 MG CAPSULE 0 RARE DISEASE EABND 00185-0714-01 2.17368 ORPHENADRINE COMP FORTE TAB 0 SANDOZ EAGEN 00115-2011-01 0.39390 ORPHENADRINE ER 100 MG TABLET 0 GLOBAL PHARM EAGEN 00115-2011-02 0.39390 ORPHENADRINE ER 100 MG TABLET 0 GLOBAL PHARM EAGEN 00185-0022-01 0.39390 ORPHENADRINE ER 100 MG TABLET 0 SANDOZ EAGEN 00185-0022-10 0.39390 ORPHENADRINE ER 100 MG TABLET 0 SANDOZ EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 43386-0480-24 0.39390 ORPHENADRINE ER 100 MG TABLET 0 GAVIS PHARMACEU EAGEN 43386-0480-26 0.39390 ORPHENADRINE ER 100 MG TABLET 0 GAVIS PHARMACEU EAGEN 43386-0480-28 0.39390 ORPHENADRINE ER 100 MG TABLET 0 GAVIS PHARMACEU EAGEX 00603-7634-17 0.85280 ORSYTHIA-28 TABLET 0 QUALITEST EAGEX 00603-7634-49 0.85280 ORSYTHIA-28 TABLET 0 QUALITEST EABEX 50458-0192-01 36.59470 ORTHO EVRA PATCH 0 JANSSEN PHARM. EABEX 50458-0192-15 36.59285 ORTHO EVRA PATCH 0 JANSSEN PHARM. EABEX 50458-0194-16 0.69917 1.35670 ORTHO MICRONOR 0.35 MG TABLET G JANSSEN PHARM. EABEX 50458-0251-15 4.11240 ORTHO TRI-CYCLEN LO TABLET 0 JANSSEN PHARM. EABEX 50458-0191-15 0.46850 1.24001 ORTHO TRI-CYCLEN 28 TABLET G JANSSEN PHARM. EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BEX 50458-0196-15 0.73800 1.90163 ORTHO-CEPT 28 DAY TABLET G JANSSEN PHARM. EABEX 50458-0197-15 0.49260 1.24001 ORTHO-CYCLEN 28 TABLET 0 JANSSEN PHARM. EABEX 50458-0176-15 0.73890 2.08982 ORTHO-NOVUM 1-35-28 TABLET G JANSSEN PHARM. EABEX 50458-0178-15 0.83640 1.12440 ORTHO-NOVUM 7-7-7-28 TABLET 0 JANSSEN PHARM. EAGEN 68047-0253-01 0.33555 OSCIMIN SL 0.125 MG TABLET 0 LARKEN LABS EAGEN 68047-0255-01 0.39640 OSCIMIN SR 0.375 MG TABLET 0 LARKEN LABS EAGEN 68047-0254-01 0.33922 OSCIMIN 0.125 MG ODT 0 LARKEN LABS EAGEN 68047-0252-01 0.33727 OSCIMIN 0.125 MG TABLET 0 LARKEN LABS EABND 64764-0121-03 9.42437 OSENI 12.5-15 MG TABLET G TAKEDA PHARMACE EABND 64764-0123-03 9.42437 OSENI 12.5-30 MG TABLET G TAKEDA PHARMACE EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 64764-0124-03 9.42437 OSENI 12.5-45 MG TABLET G TAKEDA PHARMACE EABND 64764-0251-03 9.42437 OSENI 25-15 MG TABLET G TAKEDA PHARMACE EABND 64764-0253-03 9.42437 OSENI 25-30 MG TABLET G TAKEDA PHARMACE EABND 64764-0254-03 9.42437 OSENI 25-45 MG TABLET G TAKEDA PHARMACE EABND 65649-0701-41 3.91245 OSMOPREP TABLET G SALIX PHARMACEU EA** PRIOR APPROVAL CODES:PA code "0" = PA not required; PA code "N" = PA requiredPA code "G" = PA required for Non Preferred drugs OR drugs not meeting clinical criteria (FQD, STEP) OR drugs inClinical Drug Review Program, the Brand Less than Generic Program or the Mandatory Generic Program*** OTC, SUPPLY AND COMPOUND PRODUCTS LISTING AT BACK OF REPORT
NEW YORK STATE DEPARTMENT OF HEALTH 02/28/2014 PAGE: 299LIST OF MEDICAID REIMBURSABLE DRUGSRX TYPE: 01 PRICING ERRORS ARE NOT REIMBURSABLE PRICES EFFECTIVE 02/28/2014LTM BASISIND NDC CODE MRA COST COST ALTERNATE FORMULARY DESCRIPTION PA CD LABELER OF MRA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 28595-0420-20 5.70210 OTOZIN EAR DROPS 0 ALLEGIS PHARMAC MLBND 54436-0010-02 341.13000 OTREXUP 10 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0010-04 341.13000 OTREXUP 10 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0015-02 341.13000 OTREXUP 15 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0015-04 341.13000 OTREXUP 15 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0020-02 341.13000 OTREXUP 20 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0020-04 341.13000 OTREXUP 20 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0025-02 341.13000 OTREXUP 25 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLBND 54436-0025-04 341.13000 OTREXUP 25 MG/0.4 ML AUTO-INJ 0 ANTARES PHARMA MLGEX 00430-0580-45 1.12980 OVCON-35 28 TABLET 0 ACTAVIS PHARMA, EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 51672-5276-04 2.63940 OVIDE 0.5% LOTION G TARO PHARM USA MLBND 00781-3094-15 14.54160 OXACILLIN 1 GM ADD-VANTAGE VL 0 SANDOZ EABND 00781-3094-92 15.98082 OXACILLIN 1 GM ADD-VANTAGE VL 0 SANDOZ EABND 00781-9110-15 14.54160 OXACILLIN 1 GM ADD-VANTAGE VL 0 SANDOZ/NOVAPLUS EABND 00781-9110-92 15.98082 OXACILLIN 1 GM ADD-VANTAGE VL 0 SANDOZ/NOVAPLUS EAGEN 00781-3099-85 9.02000 OXACILLIN 1 GM VIAL 0 SANDOZ EAGEN 00781-3099-95 10.94925 OXACILLIN 1 GM VIAL 0 SANDOZ EAGEN 00781-9109-85 9.02000 OXACILLIN 1 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 00781-9109-95 10.94925 OXACILLIN 1 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 25021-0146-10 9.02000 OXACILLIN 1 GM VIAL 0 SAGENT PHARMACE EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 55150-0127-15 9.02000 OXACILLIN 1 GM VIAL 0 AUROMEDICS PHAR EABND 00338-1013-41 0.28784 OXACILLIN 1 GM/ 50 ML INJ 0 BAXTER HEALTHCA MLGEN 00781-3103-46 86.49463 OXACILLIN 10 GM VIAL 0 SANDOZ EAGEN 00781-9113-46 86.49463 OXACILLIN 10 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 00781-9113-95 104.07975 OXACILLIN 10 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 25021-0163-99 86.49463 OXACILLIN 10 GM VIAL 0 SAGENT PHARMACE EAGEN 55150-0129-99 86.49463 OXACILLIN 10 GM VIAL 0 AUROMEDICS PHAR EABND 00781-3095-15 28.21170 OXACILLIN 2 GM ADD-VANTAGE VL 0 SANDOZ EABND 00781-3095-80 21.90370 OXACILLIN 2 GM ADD-VANTAGE VL 0 SANDOZ EABND 00781-3095-92 31.00050 OXACILLIN 2 GM ADD-VANTAGE VL 0 SANDOZ EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 00781-9112-15 28.21170 OXACILLIN 2 GM ADD-VANTAGE VL 0 SANDOZ/NOVAPLUS EABND 00781-9112-92 31.00050 OXACILLIN 2 GM ADD-VANTAGE VL 0 SANDOZ/NOVAPLUS EAGEN 00781-3101-80 17.39880 OXACILLIN 2 GM VIAL 0 SANDOZ EAGEN 00781-9111-80 17.39880 OXACILLIN 2 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 00781-9111-88 17.39880 OXACILLIN 2 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 00781-9111-95 21.24075 OXACILLIN 2 GM VIAL 0 SANDOZ/NOVAPLUS EAGEN 25021-0162-24 17.39880 OXACILLIN 2 GM VIAL 0 SAGENT PHARMACE EAGEN 55150-0128-24 17.39880 OXACILLIN 2 GM VIAL 0 AUROMEDICS PHAR EABND 00338-1015-41 0.41413 OXACILLIN 2 GM/ 50 ML INJ 0 BAXTER HEALTHCA MLGUL 59762-6002-01 0.67580 OXAPROZIN 600 MG CAPLET 0 GREENSTONE LLC. EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GUL 00093-0924-01 0.67580 OXAPROZIN 600 MG TABLET 0 TEVA USA EAGUL 00093-0924-05 0.67580 OXAPROZIN 600 MG TABLET 0 TEVA USA EAGUL 00185-0141-01 0.67580 OXAPROZIN 600 MG TABLET 0 SANDOZ EAGUL 55111-0170-01 0.67580 OXAPROZIN 600 MG TABLET 0 DR.REDDY'S LAB EAGUL 57664-0391-08 0.67580 OXAPROZIN 600 MG TABLET 0 CARACO PHARM EA** PRIOR APPROVAL CODES:PA code "0" = PA not required; PA code "N" = PA requiredPA code "G" = PA required for Non Preferred drugs OR drugs not meeting clinical criteria (FQD, STEP) OR drugs inClinical Drug Review Program, the Brand Less than Generic Program or the Mandatory Generic Program*** OTC, SUPPLY AND COMPOUND PRODUCTS LISTING AT BACK OF REPORT
Page 4 and 5:
NEW YORK STATE DEPARTMENT OF HEALTH
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249: NEW YORK STATE DEPARTMENT OF HEALTH
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498 and 499:
Page 500 and 501:
Page 502 and 503:
Page 504 and 505:
Page 506 and 507:
Page 508 and 509:
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
show all

NEW YORK STATE DEPARTMENT OF HEALTH 08/06 ... - eMedNY

Create successful ePaper yourself

Delete template?

Save as template?